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Summary
The chromosome of Mycobacterium tuberculosis
encodes five type VII secretion systems (ESX-1–ESX-
5). While the role of the ESX-1 and ESX-3 systems in
M. tuberculosis has been elucidated, predictions for
the function of the ESX-5 system came from data
obtained in Mycobacterium marinum, where it trans-
ports PPE and PE_PGRS proteins and modulates
innate immune responses. To define the role of the
ESX-5 system in M. tuberculosis, in this study, we
have constructed five M. tuberculosis H37Rv ESX-5
knockout/deletion mutants, inactivating eccA5, eccD5,
rv1794 and esxM genes or the ppe25-pe19 region.
Whereas the Mtbrv1794ko displayed no obvious phe-
notype, the other four mutants showed defects in
secretion of the ESX-5-encoded EsxN and PPE41, a
representative member of the large PPE protein family.
Strikingly, the MtbeccD5ko mutant also showed
enhanced sensitivity to detergents and hydrophilic
antibiotics. When the virulence of the five mutants was
evaluated, the MtbeccD5ko and MtbDppe25-pe19
mutants were found attenuated both in macrophages
and in the severe combined immune-deficient mouse
infection model. Altogether these findings indicate an
essential role of ESX-5 for transport of PPE proteins,
cell wall integrity and full virulence of M. tuberculosis,
thereby opening interesting new perspectives for the
study of this human pathogen.
Introduction
Mycobacterium tuberculosis, the etiological agent of
human tuberculosis, employs distinct pathways that
mediate protein transport across the complex mycobac-
terial cell envelope (Bitter et al., 2009): (i) the SecA1-
operated pathway, responsible for the secretion of
proteins carrying typical N-terminal signal sequences,
and an alternative SecA2-operated pathway for proteins
lacking such sequences; (ii) the twin arginine transloca-
tion (TAT) system, devoted to the secretion of proteins
with atypical N-terminal signal sequences containing two
arginine residues; and (iii) the recently described type VII
secretion pathway, known to secrete Esx proteins with
characteristic WXG100 motifs (Pallen, 2002).
The genome of M. tuberculosis harbours five gene
clusters coding for type VII secretion systems, designated
ESX-1–ESX-5 (Cole et al., 1998; Tekaia et al., 1999).
ESX-1 is the most extensively studied, due to its crucial
implication in virulence of pathogenic mycobacteria medi-
ated by secretion of effector molecules such as EsxA
(6 kDa Early Secreted Antigenic Target, ESAT-6), its
protein partner EsxB (10 kDa Culture Filtrate Protein,
CFP-10), as well as EspA and other associated proteins
(Pym et al., 2003; Fortune et al., 2005; MacGurn et al.,
2005; McLaughlin et al., 2007; Frigui et al., 2008; Gordon
et al., 2009; Simeone et al., 2009; Garces et al., 2010;
Sani et al., 2010; Bottai et al., 2011).
In the present study we focused on the ESX-5 system,
which represents the most recently evolved ESX system
(Gey van Pittius et al., 2001), encoded in the genomes of
various slow growing mycobacteria, including the human
pathogens Mycobacterium leprae and Mycobacterium
ulcerans and the fish pathogen Mycobacterium marinum,
but lacking from phylogenetically more distant saprophytic
species such as Mycobacterium smegmatis. Similarly to
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other ESX clusters, the ESX-5 locus consists of a pair of
esx genes (Fig. 1A), coding for EsxM and EsxN proteins,
immunodominant antigens, which induce strong CD4+
T-cell responses both in humans and in different animal
models (Alderson et al., 2000; Jones et al., 2010). Imme-
diately upstream of esxM/esxN the ESX-5 locus harbours
the ppe25-pe19 gene cluster, coding for members of
mycobacteria-specific protein families, named after the
conserved N-terminal proline-glutamic acid (PE) or
proline-proline-glutamic acid (PPE) motifs (Cole et al.,
1998; Tekaia et al., 1999). The ppe-pe-esx genes are
flanked by blocks of ecc (esx conserved components)
genes that encode membrane proteins and ATP-binding
proteins, predicted to be components of an ATP-powered
secretion machine involved in the export of the corre-
sponding Esx proteins (Brodin et al., 2004; Bitter et al.,
2009). First insights into the role of ESX-5 were gained
in the last few years by using M. marinum as model
(Abdallah et al., 2006; 2009; Daleke et al., 2011; Weer-
denburg et al., 2012). Analysis of secretomes of two
M. marinum ESX-5 transposon mutants revealed that
a functional ESX-5 system is required for secretion/
transport of various PPE and PE proteins, such as
the heterogeneously expressed PPE41 protein from
M. tuberculosis (Abdallah et al., 2006) or PPE and PE
proteins belonging to the PPE_MPTR and PE_PGRS
subgroups (Abdallah et al., 2009). PPE_MPTR and
PE_PGRS, characterized by C-terminal domains contain-
Fig. 1. Selective inactivation of ESX-5 genes in M. tuberculosis H37Rv.
A. Genomic organization of the ESX-5 locus in M. tuberculosis H37Rv. The various ESX-5 genes encoding proteins belonging to different
protein families are represented by coloured arrows (Gey van Pittius et al., 2006; Bitter et al., 2009): orange, amino-terminal transmembrane
protein; violet, amino-terminal transmembrane ATPase; yellow, PPE family; light green, PE family; light blue, CFP-10 (EsxB)-homologue; blue,
ESAT-6 (EsxA)-homologue; black, Rv1794 (orthologous to the M. marinum ESX-5-associated MMAR_2676 gene); green, integral membrane
protein; red, mycosin (subtilisin-like serine protease); pink, AAA+ ATPase. Black arrows indicate region-associated genes coding for proteins
not thought to be involved in the ESX-5 secretion machinery.
B. Schematic representation of genomic organization of ESX-5 mutants. In each mutant strain, only the arrow representing the mutated gene
is depicted. The grey boxes represent the kanamycin resistance cassettes used to inactivate the various ESX-5 genes.
C–E. Analysis of esxM–esxN expression in WT M. tuberculosis (C), MtbDppe25-pe19 (D) and MtbesxMko (E) mutants by RT-PCR using
various combinations of primers specific for esxM and esxN. As control, RT-PCR was performed with primers specific for rRNA 16S or pe19.
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ing Major Polymorphic Tandem Repeats (PPE_MPTR) or
a Polymorphic GC-Rich Sequence (PE_PGRS), are the
phylogenetically most recent subclasses of PE and PPE
proteins, whose massive expansion is closely associated
with the ESX-5 cluster (Gey van Pittius et al., 2006).
Recently, also the M. tuberculosis LipY lipase (LipYMt) and
its orthologous protein in M. marinum (LipYMm) were found
to be targeted to the cell surface of M. marinum in an
ESX-5-dependent manner (Daleke et al., 2011). Due to
its role in the transport of PE and PPE proteins in
M. marinum, ESX-5 is predicted to play a major role in the
interaction of pathogenic mycobacteria with the host.
Although the exact function of most of PPE and PE pro-
teins is still unknown, several of these proteins have been
proposed to be virulence factors (Ramakrishnan et al.,
2000; Brennan et al., 2001; Li et al., 2005). Because of
their abundance (pe and ppe genes account for 7.1% of
the coding capacity of the M. tuberculosis genome) (Cole
et al., 1998), their surface localization (Sampson et al.,
2001; Banu et al., 2002; Cascioferro et al., 2007; Song
et al., 2008; Chaturvedi et al., 2010) and the highly poly-
morphic nature of the C-terminal domain, PPE and PE
proteins are thought to be implicated in antigenic variation
of mycobacterial strains (Delogu and Brennan, 2001;
Bottai and Brosch, 2009).
In contrast to M. marinum, the biological function of the
ESX-5 system in M. tuberculosis, as well as the impact of
this system in virulence and host-pathogen interaction
remain largely unknown. In the present study, in order to
identify the elements constituting the M. tuberculosis
ESX-5 secretion machinery, and to evaluate their involve-
ment in PPE/PE transport and virulence, various genes
from the ESX-5 locus were inactivated or deleted in
M. tuberculosis H37Rv. The mutants were then tested in
vitro for their ability to secrete EsxN and export various
PPE and PE proteins, such as PPE41 and PE_PGRS
proteins. Moreover, to investigate the impact of different
ESX-5 genes on virulence of M. tuberculosis, the growth
properties of all ESX-5 mutants were analysed in ex
vivo/in vivo models, i.e. murine macrophages and severe
combined immune-deficient (SCID) mice. This approach
allowed us to characterize the ESX-5 system of
M. tuberculosis H37Rv and demonstrate the importance
of this system for the transport of particular ESX and PPE
proteins and full virulence of the pathogen.
Results
Identification of ESX-5 genes required for EsxN
secretion in M. tuberculosis
Five M. tuberculosis H37Rv knockout (KO) mutants were
constructed, in which selected ESX-5 genes were inacti-
vated by insertion of a kanamycin resistance cassette, or
from which a defined genomic segment of the ESX-5
locus was deleted (Fig. 1B). MtbeccA5ko and MtbeccD5ko
are inactivated for eccA5Mt (rv1798) or eccD5Mt (rv1795),
which code for an AAA+ ATPase (EccA5) or a putative
transmembrane protein (EccD5) of the ESX-5 secretion
machinery respectively. In the Mtbrv1794ko strain, gene
rv1794 is interrupted, whose orthologue in M. marinum
(MMAR_2676) encodes a protein with unknown function
involved in ESX-5-linked secretion (Abdallah et al., 2009).
In MtbesxMko, gene esxM (rv1792) is inactivated, which
is encoding a WXG-100 member in the ESX-5 region.
Finally, MtbDppe25-pe19 is lacking the genomic segment
containing the ESX-5-associated ppe25-pe19 (rv1787–
rv1791) genes. For each mutant, a complemented deriva-
tive was constructed, in which the cosmid I104, carrying
the entire ESX-5 cluster, was stably integrated into the
chromosome via the attB site, following a strategy that
has previously allowed to successfully complement ESX-
related mutant strains (Pym et al., 2003; Brodin et al.,
2010; Bottai et al., 2011). Southern hybridization patterns
displayed by M. tuberculosis wild-type (WT), KO con-
structs and complemented strains confirmed the partial
replacement of the selected ESX-5 genes by a kanamycin
cassette in the different mutants as well as the presence
of an intact ESX-5 cluster in complemented strains
(Fig. S1).
Expression studies by reverse-transcription PCR (RT-
PCR) on RNAs obtained from WT and ESX-5 mutant
strains (Fig. 1C–E) demonstrated that the esxM gene is
co-transcribed with the paired gene esxN (Fig. 1C). As
expected, inactivation of other ESX-5 genes, such as
rv1794, eccD5Mt and eccA5Mt, did not affect expression of
esxM/N (data not shown). The esxM/N genes were still
transcribed in the MtbDppe25-pe19 strain (Fig. 1D), indi-
cating that ESX-5-associated pe and ppe genes are not
required for the expression of downstream esxM/N genes.
In contrast, the disruption of esxM also abolished the
esxN transcription (Fig. 1E), thus indicating that the
MtbesxMko strain is actually a double KO strain for
the two esx genes encoded by the ESX-5 locus, similar as
what was observed for the esxB/A couple of the ESX-1
system (Brodin et al., 2006).
To investigate whether selected M. tuberculosis ESX-5
KO mutants displayed a defect in EsxN secretion, culture
filtrates as well as total lysates from WT, ESX-5 KO and
complemented strains were tested in Western blot analy-
ses using an anti-EsxN polyclonal serum. As shown in
Fig. 2A, large amounts of EsxN were detected in the
culture filtrates as well as in total lysates of M. tuberculosis
H37Rv WT and the Mtbrv1794ko mutant. Lysis controls
using antibodies against GroEL2 demonstrated that these
samples were not contaminated with cytosolic or mem-
brane associated proteins, thus indicating that in contrast
to its M. marinum orthologue, Rv1794 is not directly
involved in EsxN secretion in M. tuberculosis. Conversely,
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no EsxN was detected in the culture supernatants from
MtbeccD5ko and MtbeccA5ko mutants, despite a 10 kDa
specific band corresponding to EsxN observed in the total
lysates from both these strains (Fig. 2A). These results
indicate that eccD5Mt and eccA5Mt are required for an effi-
cient translocation of EsxN. Interestingly, no EsxN specific
band was detected in the culture supernatants from
the MtbDppe25-pe19 strain, suggesting that ESX-5-
associated -PPE and -PE proteins also play a role in the
export of this protein. In contrast to expression studies,
showing a tight link between esxM and esxN expression
(Fig. 1), a 10 kDa band was recognized by the anti-EsxN
polyclonal serum in the total lysates from the MtbesxMko
mutant. The M. tuberculosis genome harbours four other
esxN-like genes not associated to any ESX cluster (Cole
et al., 1998; Uplekar et al., 2011), which are co-transcribed
with their paired esxM-like genes during the in vitro growth
(data not shown). EsxN and the four EsxN-like proteins,
collectively known as Mtb9.9 family (Alderson et al., 2000),
share highly similar protein sequence, differing only by a
few amino acids. When immunoblot analysis was per-
formed on culture supernatants subjected to 2D gel elec-
trophoresis, four different spots were detected in the
culture supernatants from the WT strain as well as from the
Mtbrv1794ko mutant (Fig. 2C). The absence of specific
spots recognized by the anti-EsxN serum in the culture
filtrates from the KO mutants suggests that ESX-5 is
involved in the secretion of all Mtb9.9 proteins and that
secretion of EsxN and/or EsxM is required for secretion of
other Mtb9.9 family members. However, the exact identifi-
cation by mass spectrometry of the four spots recognized
by the anti-EsxN serum was unsuccessful, due to low
amount of the proteins. For this reason, it cannot be
excluded that some spots might represent different iso-
Fig. 2. In vitro expression and secretion of EsxN in M. tuberculosis ESX-5 mutants.
A and B. Fifteen micrograms of culture filtrate (CF) or total cell lysate (TL) proteins from ESX-5 mutants (A) and their complemented
derivatives (B) were subjected to SDS-PAGE and tested in Western blotting by using a rabbit anti-EsxN polyclonal serum. Mouse anti-GroEL2
antibody was used for lysis control.
C. Two-dimensional analysis and immunoblot of CF from M. tuberculosis WT, ESX-5 KO and complemented strains. Fifty micrograms of
culture supernatants were separated by isofocusing using a pH 4.5–5.5 gradient and 4–20% SDS-PAGE, in the first and second dimension
respectively. Protein detection was carried out by immunoblot using the anti-EsxN polyclonal serum as previously described. For simplicity,
only the region of the filter containing the anti-EsxN-recognized spots is shown.
D. Expression and secretion of EsxA in ESX-5 mutant strains. CF and TL proteins from WT M. tuberculosis and ESX-5 mutants were
subjected to SDS-PAGE and tested in Western blot using the anti-ESAT-6 Hyb76-8 monoclonal antibody. As depicted in A, culture filtrates
were negative for GroEL2. Preparations from the MtbDDRD1 strain were included in the immunoblotting analysis as negative control.
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forms of EsxN, resulting from post-transcriptional modifi-
cations. As depicted in Fig. 2B and C, secretion of EsxN
was restored in all complemented strains.
Preliminary experiments in M. marinum suggested a
potential cross-interaction between ESX-1 and ESX-5
(A. Abdallah and W. Bitter, unpubl. obs.). To investigate
whether the inactivation of ESX-5 could affect the secretion
of ESX-1 substrates, culture filtrates from all ESX-5
mutants were tested in Western blotting for the presence of
EsxA (ESAT-6). Whereas no EsxA was observed in culture
filtrates from the negative control strain MtbDDRD1 (Bottai
et al., 2011) (Fig. 2D), similar amounts of the protein were
detected in samples from various ESX-5 mutants and WT
M. tuberculosis (Fig. 2D), suggesting that the inactivation
of different components of the ESX-5 secretion apparatus
has no relevant impact on EsxA production and secretion.
PPE41 and PE_PGRS secretion/transport in ESX-5
mutant strains
Previous findings in M. marinum showed that various PPE
and PE proteins, such as PPE41 and PE_PGRS, are
exported in an ESX-5-dependent manner (Abdallah et al.,
2006; 2009). In order to investigate whether these pro-
teins were secreted/transported via the ESX-5 system
also in M. tuberculosis, all ESX-5 mutants, their comple-
mented derivatives and the WT strain were tested for
their ability to secrete PPE41 and PE_PGRS proteins in
the same growth conditions that have been previously
described for M. marinum ESX-5 mutants using Middle-
brook 7H9 medium (Abdallah et al., 2006; 2009). As
shown in Fig. 3A, a specific band of 23 kDa correspond-
ing to PPE41 was observed in culture supernatants from
Fig. 3. Effect of ESX-5 inactivation on PPE41 secretion and transport.
A and B. Culture supernatants and total lysates from WT M. tuberculosis and ESX-5 mutants (A) or complemented strains (B) were tested in
Western blot with anti-PPE41 rabbit polyclonal serum. As control, samples were tested with a mouse anti-GroEL2 antibody or a rabbit
polyclonal serum anti-PPE68.
C. Proteinase K sensitivity assay performed on WT M. tuberculosis, Mtbrv1794ko, MtbeccD5ko and MtbeccA5ko. Live bacteria were incubated
with (+) or without (-) proteinase K, and the whole cell lysates obtained from treated and untreated bacteria were separated by SDS-PAGE.
PPE41 and PPE68 detection was carried out by immunoblotting as previously reported.
D. Ten micrograms of cytoplasm (CYT), membrane (ME) and cell wall (CW) proteins from WT M. tuberculosis, MtbeccD5ko and MtbeccA5ko
strains were tested in Western blot using anti-PPE41 and anti-PPE68 polyclonal sera.
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the M. tuberculosis control strain as well as in prepara-
tions from Mtbrv1794ko and MtbesxMko strains. PPE41
was still detected in the culture supernatants from the
MtbeccA5ko mutant, although the amounts were substan-
tially lower than those detected in samples from the WT
strain. In contrast, a clear defect in PPE41 secretion was
observed for MtbeccD5ko: no specific band corresponding
to PPE41 was indeed detected in the culture supernatants
from this strain, despite the presence of a PPE41-specific
band in the whole cell lysates. Similarly, no PPE41 was
detected in culture filtrates from MtbDppe25-pe19, further
suggesting that ESX-5 encoded PE and PPE proteins
might be involved in the ESX-5 secretion machinery.
Secretion of PPE41 in culture supernatants was restored
in MtbeccD5ko-C and MtbDppe25-pe19-C complemented
strains (Fig. 3B).
When samples were tested with the anti-PGRS anti-
body, a few PE_PGRS proteins were observed in the
culture filtrates of M. tuberculosis H37Rv. However,
although some differences in the amounts of PE_PGRS
proteins were detected in culture filtrates from various
ESX-5 KO and complemented strains (Fig. S2), variations
in the protein pattern recognized by the anti-PGRS anti-
body appeared to be weaker than differences previously
observed in ESX-5 M. marinum mutants (Abdallah et al.,
2009). No significant difference was detected among the
strains when the analysis of PE_PGRS secretion was
performed on culture supernatants obtained from bacteria
grown in Sauton medium (data not shown). The lack of
GroEL2 and PPE68 in culture supernatants from all tested
strains confirmed the absence of contamination of these
samples with cell-associated proteins (Fig. 3A and B).
To investigate more in-depth the impact of eccD5Mt
inactivation on transport of PPE41 and PE_PGRS, the
localization of these proteins was determined both in WT
and MtbeccD5ko strains as well as in Mtbrv1794ko and
MtbeccA5ko mutants by proteinase K assays and Western
blot analysis of subcellular fractions. As control, the local-
ization of PPE68 was analysed. The proteinase K treat-
ment removed the majority of PPE41 in M. tuberculosis
WT, Mtbrv1794ko and MtbeccA5ko (Fig. 3C), indicating
that in these strains the protein is exposed on the bacterial
surface. In contrast, the protein was (partially) resistant to
the protease treatment in the MtbeccD5ko mutant, sug-
gesting that PPE41 is not exposed on the cell surface of
this strain. Western blot analysis of cytosol, membrane and
cell wall fractions with the anti-PPE41 antibody demon-
strated that the protein was mainly associated to mem-
brane and cell wall in the WT M. tuberculosis strain and
MtbeccA5ko mutant. In contrast, the protein accumulated
in the cytoplasm and membrane fractions in MtbeccD5ko
(Fig. 3D), further confirming an involvement of EccD5 in the
transport of PPE41. These analyses revealed substantially
lower amounts of PPE41 in the MtbeccD5ko mutant as
compared to the control strain. It cannot be excluded that
the protein might have a reduced stability as consequence
of its altered localization. Sensitivity to proteinase K treat-
ment and translocation to cell wall were restored in the
MtbeccD5ko-C complemented derivative (Fig. 3C and D).
Western blot analysis of proteinase-K-treated sample
from WT M. tuberculosis H37Rv with the anti-PGRS mono-
clonal antibody revealed that some PE_PGRS proteins
were sensitive to protease digestion and thus exposed to
the mycobacterial surface (data not shown). In agreement
with data from secretion analyses, PE_PGRS protein pat-
terns from proteinase K-treated WT M. tuberculosis H37Rv
and ESX-5 mutants revealed no appreciable differences
between WT and mutant strains (data not shown). Similarly
as what was observed in samples from WT M. tuberculo-
sis, PPE68 was resistant to protease treatment and effi-
ciently translocated to membrane and cell wall also in the
MtbeccD5ko mutant (Fig. 3C and D), thus suggesting that
this ESX-1-associated protein is not exposed on the myco-
bacterial surface and is transported to the cell wall in an
ESX-5-independent manner. Together, these results indi-
cate that in M. tuberculosis, a functional ESX-5 system is
required for an efficient translocation and a correct local-
ization of PPE41.
Effect of ESX-5 inactivation on cell wall integrity
To investigate the impact of ESX-5 inactivation on cell wall
integrity/stability, the survival of the MtbeccD5ko and WT
M. tuberculosis after exposure to detergents was com-
pared. Bacteria in logarithmic growth phase were exposed
to 0.1% SDS treatment and after 6 h viable bacteria were
counted. Although the addition of the detergent caused a
rapid decrease in the cfu numbers recovered for all the
tested strains (Fig. 4A), the MtbeccD5ko mutant showed
an enhanced sensitivity to SDS as compared to control
strains: the percentage survival values were 1% for the
MtbeccD5ko mutant and 10% for the WT or the comple-
mented MtbeccD5ko-C strains respectively (Fig. 4B). The
greater sensitivity of the MtbeccD5ko mutant to SDS was
confirmed when bacterial survival was assessed after 24
and 72 h of incubation with SDS (data not shown). The
sensitivity of the other ESX-5 KO strains was comparable
to that of the parental strain (Fig. 4).
The mycobacterial cell envelope, which represents an
effective barrier to both hydrophobic and hydrophilic
solutes, is considered a major determinant of the intrinsic
resistance of M. tuberculosis to different antibiotics
(Brennan and Nikaido, 1995). Thus, alterations in cell wall
integrity may also be detected by measuring the suscep-
tibility of mycobacteria to various antibiotics. To further
evaluate the effects of eccD5Mt inactivation on cell wall
properties, the susceptibility of MtbeccD5ko, WT M. tuber-
culosis and other ESX-5 mutants (e.g. MtbDppe25-pe19)
1200 D. Bottai et al. 
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to various classes of antibiotics with diverse chemical
structure and mechanism of action to which mycobacteria
are naturally resistant was compared (Jackson et al.,
1999). These included antibiotics targeting several steps in
the cell wall biosynthetic pathway, such as ampicillin, baci-
tracin and vancomycin; antibiotics targeting DNA replica-
tion such as ofloxacin and norfloxacin; antibiotics targeting
transcription, such as rifampicin, which is also a front-line
anti-tuberculosis drug. Isoniazid and ethambutol, two anti-
biotics affecting the cell wall biosynthesis, to which myco-
bacteria are susceptible, were included in the analysis for
control purposes. As shown in Table 1, while all strains
displayed comparable sensitivity to isoniazid and etham-
butol, the MtbeccD5ko mutant was highly sensitive to
ampicillin, vancomycin and bacitracin. The MIC values for
these antibiotics were indeed 32- or 64-fold lower for the
Fig. 4. Effect of EccD5 disruption on cell wall integrity of M. tuberculosis.
A and B. Sensitivity of MtbeccD5ko and other ESX-5 mutants to SDS. Bacterial strains were exposed to SDS 0.1% for 6 h and the number of
cfu (A) and the survival percentages (B) were determined. The means and the standard deviations of cfu values and survival percentages
obtained in four independent experiments are shown. The significant difference in cfu and survival percentage values between H37Rv and
MtbeccD5ko strain was determined by one-way ANOVA test, followed by Bonferroni post-hoc test (*P < 0.05).
C. Growth of MtbeccD5ko on solid medium. Three-week-old cultures of MtbeccD5ko, M. tuberculosis WT and the MtbeccD5ko-C strain grown
on Middlebrook 7H11 medium. Bacterial cultures were washed, resuspended and serially 10-fold diluted in PBS: a sample of 20 ml of each
dilution was spotted onto agar plates.
Table 1. Drug sensitivity of MtbeccD5ko mutant.
MtbeccD5ko Mtb MtbeccD5ko-C
Ampicillin (mg ml-1) 12.5 400 n.a.
Bacitracin (mg ml-1) 6.25 400 400
Vancomycin (mg ml-1) 1.25 >40 10
Norfloxacin (mg ml-1) 1.25 2.5 2.5
Ofloxacin (mg ml-1) 0.125 1 0.5
Rifampicin (mg ml-1) 0.03 0.06 0.06
Isoniazid (mg ml-1) 0.5 0.5 0.5
Ethambutol (mg ml-1) 3.2 3.2 3.2
MIC values were determined as the lowest concentration of antibiotic
which reduced the bacterial viability by at least 99% on solid medium.
n.a.: not applicable due to the presence of an ampicillin resistance
gene in the cosmid used for the construction of the complemented
strain.
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MtbeccD5ko mutant than those of the WT strain (Table 1)
or the MtbDppe25-pe19 mutant (data not shown). The
enhanced sensitivity of the MtbeccD5ko strain to hydro-
philic antibiotics was confirmed when the susceptibility was
tested by using the microplate-based nitrate reductase
assay in broth (Kumar et al., 2005). In this case, the MIC
values for ampicillin, vancomycin and bacitracin were
0.25, 0.5 and 8 mg ml-1 for MtbeccD5ko and 100, 8
and 256 mg ml-1 for the WT M. tuberculosis H37Rv or
MtbDppe25-pe19 respectively. These results thus suggest
that the inactivation of the ESX-5 system via the disruption
of EccD5 strongly affects the mutant’s cell wall stability. This
effect was also visible by inspection of the MtbeccD5ko
mutant on Middlebrook 7H11 plates, which was character-
ized by a small colony phenotype that was reverted upon
complementation with the cosmid encoding a functional
ESX-5 system (Fig. 4B). It is noteworthy that the
MtbeccD5ko strain also displayed smaller colonies than the
M. tuberculosis H37Rv control on Middlebrook 7H9 agar
plates without malachite green (data not shown), thus
suggesting that the small colony morphotype of the EccD5
mutant is not due to the presence of this inhibitory agent in
the medium. The finding that the MtbeccD5ko mutant
showed no difference in growth as compared to the WT
strain in liquid medium (Fig. S3) further emphasizes the
importance of EccD5 and ESX-5 in general for a fully
functional cell envelope that determines the contact with its
immediate environment.
Growth of the ESX-5 mutant strains in macrophages
To investigate the effect of ESX-5 inactivation on intra-
cellular growth characteristics of M. tuberculosis, the ex
vivo growth of the ESX-5 mutants and the WT strain
were compared in bone marrow-derived macrophages
(BMDM). Cells were infected with the various strains at a
multiplicity of infection (moi) of 1:1, and the number of
intracellular bacteria was determined at 4 h, and 1, 4 and
7 days after infection. The ESX-5 mutants were taken up
by BMDM with similar efficiency as the M. tuberculosis
WT (data not shown), indicating that inactivation of differ-
ent components of the ESX-5 system has no relevant
impact on the ability of M. tuberculosis to be engulfed by
host macrophages.
In contrast, when the ex vivo growth kinetics of the
various ESX-5 KO strains were analysed, differences in
their intracellular growth abilities were observed (Fig. 5).
The Mtbrv1794ko, MtbesxMko and MtbeccA5ko mutants
showed intracellular growth kinetics similar to that of the
M. tuberculosis WT, resulting in 1 log10 increase in the cfu
number over a 7 day period. It should be mentioned,
however, that the MtbeccA5ko showed impaired growth as
compared to the WT M. tuberculosis H37Rv in THP-1-
derived macrophages and type II pneumocyte cell line
(A549) (Fig. S4). An attenuated phenotype in murine
macrophages was observed for MtbDppe25-pe19 and
MtbeccD5ko mutants. Seven days after infection, only a
0.5 log10 increase was indeed observed in the cfu
numbers recovered from macrophages infected with this
mutant strain MtbDppe25-pe19. An even stronger attenu-
ation phenotype was displayed by the MtbeccD5ko mutant
for which no growth was observed in murine macro-
phages over the same period. Complementation of
MtbDppe25-pe19 and MtbeccD5ko strains with an entire
ESX-5 cluster increased the intracellular growth ability of
the mutants, resulting in a 0.8 log10 increase in the cfu
numbers recovered from infected cells after 7 days from
infection.
Fig. 5. Intracellular growth of ESX-5 mutant strains in BMDM. BMDM (1 ¥ 104 cells per well) obtained from C57BL/6 mice were infected with
various ESX-5 mutants, their corresponding complemented derivatives, and the WT M. tuberculosis H37Rv strain using an moi of 1:1. cfu
numbers of intracellular bacteria were determined 4 h, and 1, 4 and 7 days after infection. The figure shows the average of cfu numbers (A)
and fold growth values (cfu/cfu at day 0) (B) obtained in one experiment performed in triplicate.
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Virulence of the ESX-5 mutants in SCID mice
The impact of ESX-5 inactivation on virulence of M. tuber-
culosis was assessed by evaluating the in vivo growth of
ESX-5 mutants in SCID mice. In agreement with results
obtained from murine macrophage infection studies, the
MtbeccA5ko, MtbesxMko and Mtbrv1794ko mutants dis-
played a rapid growth both in spleen and lungs of infected
mice (Fig. 6A–D), as indicated by high bacterial load in the
target organs (108–109 cfu) and severe splenomegaly
(data not shown), comparable to those observed for the
M. tuberculosis WT.
Conversely, the MtbDppe25-pe19 mutant showed a
strongly attenuated phenotype. Three weeks after infec-
tion, a 3- and 2-log10 reduction was observed in the
numbers of cfu recovered from spleen and lungs of
Fig. 6. Virulence of different ESX-5 mutant strains in a SCID mouse infection model. SCID mice were infected intravenously with 1 ¥ 106 cfu
per mouse of various ESX-5 mutant and control strains. A, C and E depict the average cfu numbers recovered from the spleen of groups of
three to four mice in three independent experiments at day 1 and day 21 post infection. B, D and F show the average cfu numbers in the
lungs of the same groups of mice.
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MtbDppe25-pe19-infected mice relative to the M. tubercu-
losis H37Rv-infected controls (Fig. 6A–D). Levels of viru-
lence similar to those of the M. tuberculosis control strain
were restored in the ESX-5 complemented MtbDppe25-
pe19-C derivative (Fig. 6C and D). The MtbeccD5ko strain
showed an even stronger attenuation: inactivation of
eccD5Mt gene resulted indeed in no growth either in spleen
or lungs of infected mice over a 21 day period (Fig. 6C and
D), and reduced splenomegaly (data not shown). Comple-
mentation of MtbeccD5ko with a functional ESX-5 system
increased the in vivo growth of the strain, resulting in a 3
log10 increase in numbers of cfu recovered in spleen and
lungs, although it did not restore the virulence to the level of
the WT strain.
The severe attenuation of the MtbeccD5ko mutant was
further confirmed when the in vivo growth of this strain
was compared to that of the vaccine strain Mycobacte-
rium bovis BCG (BCG) and the partially virulent
BCG::RD1 (Brodin et al., 2006). As depicted in Fig. 6E
and F, no growth was observed for the MtbeccD5ko
mutant, whereas 1- and 2-log10 increase in cfu number
was observed in spleen and lungs of mice infected with
BCG and BCG::RD1 strains respectively.
Discussion
The role of the ESX-5 system in the export of selected
PPE and PE proteins in M. marinum, as well as the
involvement of this system in modulation of cytokine
responses by M. marinum-infected human macrophages
are well established (Abdallah et al., 2006; 2008; 2009;
Daleke et al., 2011). In contrast, nothing is known about
the function of the ESX-5 system in M. tuberculosis. The
present study was thus focused on the characterization of
the ESX-5 system of M. tuberculosis on the basis of
ESX-5 KO and deletion constructs.
As a first conclusion drawn from the results obtained,
the characteristics of different mutants and the positions
of the corresponding inactivated genes argue against the
possibility that the phenotypes displayed by the various
ESX-5 mutants (with exception of the EsxM/N couple, for
which a downstream effect of esxM disruption on esxN
was observed) were due to polar effects on the expres-
sion of downstream genes. Screening of ESX-5 mutants
for their ability to secrete EsxN showed that eccA5Mt and
eccD5Mt are required for secretion of EsxN. These genes
are homologous to eccA1Mt (rv3868) and eccD1Mt (rv3877),
both encoding for components of the ESX-1 secretion
apparatus involved in transport of ESAT-6 and CFP-10
(Brodin et al., 2006). In contrast to the ESX-1-encoded
pe35 gene that is implicated in the expression of esxB/
esxA (Brodin et al., 2006), the ESX-5-associated pe and
ppe genes are dispensable for the expression of esxM/N
but required for secretion of EsxN. Finally, rv1794, the
orthologue of MMAR_2676, which in M. marinum was
reported to affect EsxN secretion and export of various PE
and PPE proteins (Abdallah et al., 2009), is not implicated
in the secretion of EsxN in M. tuberculosis H37Rv. These
findings suggest that in spite of high amino acid similarity
(96% identity), Rv1794 and MMAR_2676 might have dif-
ferent functions in the ESX-5 secretion machinery that
have evolved as a consequence of the adaptation of
these two mycobacterial species to different hosts. Sub-
stantial differences in function of proteins encoded by
ESX clusters from different mycobacterial species have
been previously described for the ESX-1 secretion-
associated protein EspG1 (Bottai et al., 2011), which
shows weak similarity with Rv1794. While EspG1Mm is
required for EsxA secretion and virulence in M. marinum
(Gao et al., 2006), the EspG1Mt is not directly involved
in EsxA secretion, although it plays a relevant role in
virulence of M. tuberculosis (Bottai et al., 2011). Alterna-
tively, the function of Rv1794 could be redundant in
M. tuberculosis.
PPE41 secretion and localization studies in M. tubercu-
losis ESX-5 mutant strains confirmed previous findings in
M. marinum showing a major role of the ESX-5 secretion
system in PPE export. However, the various components
of the ESX-5 secretion apparatus seem to have a different
impact on this process. Whereas only minor reduction of
PPE41 transport was observed after disruption of the
eccA5Mt gene, the inactivation of eccD5Mt abolished the
secretion of PPE41, and also resulted in a profound reduc-
tion of the amounts of PPE41 transported to the bacterial
envelope. It is plausible that the different phenotypes
exhibited by EccD5 and EccA5 mutants might be caused by
a deviating involvement of the proteins in the stability of the
ESX-5 secretion machinery. Recently, biochemical charac-
terization of ESX-5 components in M. marinum and BCG
suggested that EccD5 is part of a four-membered protein
complex forming the core of the ESX-5 secretion appara-
tus, whereas EccA5 is not part of this complex (E. Houben,
pers. comm.). Thus, disruption of a core component,
such as EccD5, likely abolishes the stability of the entire
complex. In support of this hypothesis, preliminary immu-
noblotting experiments identified much lower amounts of
EccB5, another ESX-5 core component, in membrane and
cell wall fractions of MtbeccD5ko relative to WT and
MtbeccA5ko strains (Fig. S5). These results suggest that
EccD5 and EccB5 are indeed part of the same core
complex, which does not include EccA5 (Fig. S5) or ESX-
5-associated PE and PPE proteins (data not shown). In
addition, the minor effect of eccA5 disruption in M. tuber-
culosis on PPE41 secretion compared to M. marinum
(Abdallah et al., 2006) might also be due to a possible
redundancy of eccA5 with homologues eccA genes from
other ESX systems such as ESX-2, which is not present in
the genome of M. marinum (Stinear et al., 2008). However,
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as deletion of the ESX-2 cluster in the MtbeccA5ko genetic
background did not interrupt the PPE41 secretion in the
double mutant (data not shown), this does not seem to be
the case. The example of eccA5, like for rv1794 and espG1,
shows again that in spite of the high conservation of ESX
loci between M. marinum and M. tuberculosis certain
genes might not have the same impact in one species than
in the other. Finally, it cannot be excluded that other AAA+
ATPases specifically present in M. tuberculosis might
complement for the loss of EccA5Mt function.
No obvious effect on PE_PGRS proteins exposed on the
cell surface or released in the culture supernatants was
detected after inactivation of different components of the
ESX-5 secretion machinery in M. tuberculosis H37Rv.
These results are in contrast with previous observations
in M. marinum, where several M. marinum specific
PE_PGRS proteins are secreted in an ESX-5-dependent
manner (Abdallah et al., 2009). A number of studies
suggest that some PE_PGRS and PPE proteins are asso-
ciated with the cell envelope. It is possible that the impact
of ESX-5 inactivation on release of PE_PGRS proteins is
also affected by the composition of the cell wall. For
example, cell wall of M. marinum contains a group of
glycolipids, designated lipooligosaccharides (LOSs),
which are absent from the cell wall of M. tuberculosis
H37Rv and several M. tuberculosis clinical isolates (Ren
et al., 2007). As the number and composition of PE_PGRS
proteins as well as their expression profiles vary consider-
ably among different M. tuberculosis strains (Voskuil et al.,
2004), strain specific differences in PE_PGRS secretion
patterns might as well occur.
Although the growth of M. tuberculosis in liquid medium
is not affected by disruption of individual components of the
ESX-5 secretion machinery (Fig. S3), the virulence prop-
erties of M. tuberculosis are strictly dependent on a func-
tional ESX-5 system (Fig. 6). Disruption of eccD5 indeed
results in the loss of the ability of M. tuberculosis to repli-
cate in SCID mice. Differently from ESX-1 mutants, whose
attenuation is due to defects in EsxA/B expression or
secretion (Brodin et al., 2006), the attenuation of the
MtbeccD5ko mutant is not related to the loss of EsxN
secretion. Indeed, the characterization of the ex vivo and in
vivo growth properties of the MtbesxMko mutant demon-
strated that inactivation of esxM/esxN genes does not
result in attenuation of virulence of M. tuberculosis. The
profound attenuation of virulence of M. tuberculosis result-
ing from inactivation of eccD5 could be in part due to the
alteration of the integrity of the mycobacterial cell wall.
Alteration of cell wall structure may cause attenuation of
virulence by disrupting the bacterial interface with the host
cell, undermining specific virulence functions, or increas-
ing the susceptibility of the microorganism to host anti-
microbial defences (Barry, 2001). Such a scenario is in
good agreement with the increased sensitivity of the
MtbeccD5ko strain to detergents and antibiotics to which
mycobacteria are naturally resistant. Apart from the direct
implication of the EccD5-containing multi-membered
protein complex in cell envelope stability (see above),
some of the observed effects might also be linked to a
defect in transport of PPE proteins and/or other mycobac-
terial cell wall components in ESX-5 mutants. To date, the
function and localization of ESX-5-associated PPE and PE
proteins are unknown. However, as the virulence of the
MtbDppe25-pe19 mutant was also found to be attenuated,
it seems likely that these proteins, as well as their transport
across the cytoplasmic membrane, might play a role for a
fully functional cell envelope. Because of their high homol-
ogy in primary amino acid sequence, it cannot be excluded
that these PE and PPE proteins might play a redundant
role in M. tuberculosis virulence. Homologous recombina-
tion events between ppe25 and ppe27 genes resulting in
deletion of ppe25, pe18 and ppe26 genes have been
reported in some Tunisian clinical isolates of M. tuberculo-
sis (Karboul et al., 2008). As these clinical isolates appar-
ently conserved their virulence and infectivity, it is plausible
that not all of the five PE and PPE proteins in the ESX-5
locus, deleted in the attenuated MtbDppe25-pe19 strain,
are involved in virulence functions. However, it seems
likely that at least one PE/PPE pair from the ESX-5 region
is. A similar situation was observed in M. avium, where a
PPE25 homologue is required for growth in macrophages
and in mice (Li et al., 2005).
In agreement with the above mentioned minor effects
on PPE transport and resistance to cell wall stresses, no
defect in the virulence properties of M. tuberculosis in
SCID mice was observed after inactivation of eccA5.
However, it should be mentioned that the eccA5 gene was
recently identified as required for cholesterol catabolism
in M. tuberculosis (Griffin et al., 2011). As cholesterol
uptake and catabolism are not required for growth during
the acute phase of infection but for mycobacterial persis-
tence during the chronic phase (Pandey and Sassetti,
2008), it cannot be excluded that a more evident growth
defect might be observed for the MtbeccA5ko mutant
during long-term infection experiments. In this respect, it
is also noteworthy that eccA5 was suggested as virulence
factor in the guinea-pig infection model (Jain et al., 2007).
The impact of EccA5 on in vivo growth of M. tuberculosis
might thus vary with the type of infected host, which is
also relevant to our observation that the MtbeccA5ko
mutant strain has an impaired intracellular growth in
human THP-1 and A549 cell lines (Fig. S4).
In conclusion, the results obtained in this study demon-
strate that the ESX-5 system of M. tuberculosis has an
important function for the cell wall integrity and virulence
of M. tuberculosis. It is clear that the ESX-5 system in
M. tuberculosis shares certain basic features with the
ESX-5 system in M. marinum that can now be evaluated
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also in other M. tuberculosis lineages. However, several
differences have also been highlighted, which seem to be
specific for the system in M. tuberculosis. After the ESX-1
and the ESX-3 systems of M. tuberculosis, which were
subject of numerous publications from various research
groups, our data allow new insights to be made into the
ESX-5 system of M. tuberculosis. From comparison of the
three ESX systems studied so far in M. tuberculosis, it is
obvious that despite their different functions, each of them
plays an important role in the biology and pathogenicity of
the etiological agent of human tuberculosis, which makes
them interesting and important targets for potential new
prevention and control strategies.
Experimental procedures
Plasmids, bacterial strains and growth conditions
Plasmid pPR27, used for construction of KO strains, is a
thermosensitive vector, carrying the sacB counterselectable
marker (Pelicic et al., 1997); plasmid pUC4K (Amersham Bio-
sciences) contains the kanamycin resistance cassette (aph);
cosmid I104, used for construction of complemented strains, is
an integrative pYUB412 vector (Bange et al., 1999) containing
a 41 kb fragment (2005–2046 kb) of the M. tuberculosis
H37Rv genome including the entire ESX-5 locus. For cloning
procedures and plasmid amplification, Escherichia coli
DH10B (Invitrogen) was grown either in LB liquid or solid
medium, added when required with 20 mg ml-1 of gentamicin,
100 mg ml-1 of hygromycin or 100 mg ml-1 of ampicillin. For the
construction of mycobacterial KO mutants, M. tuberculosis
H37Rv (stocks held at the Institut Pasteur) (Cole et al., 1998)
was used as the reference strain. M. tuberculosis strains were
grown in Middlebrook 7H9 medium (Becton-Dickinson)
supplemented with albumin-dextrose-catalase (ADC, Becton-
Dickinson) or on Middlebrook 7H11 medium (Becton-
Dickinson) supplemented with oleic acid-albumin-dextrose-
catalase (OADC). When required, the media were added with
2% sucrose or the following concentrations of antibiotics:
20 mg ml-1 of kanamycin and/or 50 mg ml-1 of hygromycin and
25 mg ml-1 of gentamicin.
Construction of KO mutant and complemented strains
Knockout mutants were constructed by allelic exchange
using the Ts/sacB method (Pelicic et al., 1997). Fragments
bearing the genes of interest, 1000–1500 bp of flanking
regions, and the aph gene were synthesized by PCR (see
Table S1 for primer sequences). Amplicons corresponding to
5′ or 3′ flanking regions and kanamycin resistance cassette
were digested with the appropriate restriction endonuclease
(Table S2) and fragments obtained were cloned into BamHI-
NotI or SpeI-NotI digested pPR27 vector. The resulting con-
structs were electroporated into M. tuberculosis for allelic
replacement experiments. To obtain complemented strains,
the cosmid I104 was used. The cosmid was electroporated
into mutant strains and transformants were selected on
Middlebrook 7H11 medium supplemented with 50 mg ml-1
hygromycin. Resistant colonies were analysed for the pres-
ence of the integrated ESX-5 locus by PCR and/or Southern
blot on genomic DNA.
RNA extraction and RT-PCR reactions
RNA was extracted from bacteria in exponential growth phase
as previously described (Bottai et al., 2011) and used in
RT-PCR reactions using the SS-One Step RT-PCR kit (Invit-
rogen) in accordance with the manufacturer’s instructions.
Sequences of primers used are listed in Table S1.
Recombinant EsxN purification and production
of EsxN antisera
The esxN coding sequence was amplified by PCR from
H37Rv genomic DNA (see Table S1 for primer details) and
cloned into pET303/CT-His vector (Invitrogen). Recombinant
C-terminal 6His-tagged-EsxN (EsxN-6His) was expressed in
E. coli BL21 (Invitrogen) and purified by affinity chromatog-
raphy on Ni2+-NTA affinity columns (Invitrogen) under dena-
turing conditions. Briefly, binding of the protein to the column
was performed in 20 mM sodium-phosphate buffer contain-
ing 6 M guanidine hydrochloride, 500 mM NaCl, pH 7.8.
Elution of EsxN-6His was carried out in 20 mM sodium-
phosphate buffer, 8 M urea, 500 mM NaCl, pH 4. Removal
of contaminant proteins co-purified with EsxN-6His was
obtained by electroelution of recombinant EsxN from poly-
acrylamide gel. To generate anti-EsxN polyclonal serum the
protein preparation obtained was used for rabbit immuniza-
tion using the mineral oil-based adjuvant Stimmune (Prionics)
as recommended by the manufacturer.
Preparation of culture filtrates and total lysates from
M. tuberculosis strains and immunoblotting
Preparation of mycobacterial culture filtrates was performed
as previously described (Fortune et al., 2005; Abdallah et al.,
2009). For analysis of EsxN secretion, M. tuberculosis strains
were grown for 6 days in Sauton medium supplemented with
0.05% Tween 80. Mid-log phase bacteria were then resus-
pended in fresh Sauton medium and cultured for 4 days:
cultures were harvested by centrifugation and culture filtrates
were recovered after filtration through 0.22-mm-pore-size
filters (Millipore MillexR GP), followed by concentration using
Centricon filters with a 3 kDa cut-off (Millipore). Alternatively,
following experimental protocols described elsewhere
(Abdallah et al., 2006; 2009), mycobacterial strains were
grown to mid- or late logarithmic growth phase in Middlebrook
7H9 medium supplemented with 0.05% Tween 80. Pre-
cultures were then diluted in fresh Middlebrook 7H9 medium
supplemented with 0.1% ADC. After 6 days, culture superna-
tants were recovered and proteins were precipitated with
10% TCA. To obtain total lysates, mycobacterial pellets were
washed twice and resuspended in 20 mM Tris buffer (pH 7.5)
and cells were broken by shaking with 106 mm acid washed-
glass beads (Sigma-Aldrich) for 8 min in a Tissue Lyser appa-
ratus (Qiagen). The supernatant fraction recovered after
centrifugation at 5000 r.p.m. for 30 min represented the
whole-cell lysate. Cell wall, cytosolic and membrane fractions
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were prepared from total lysates by 60 min centrifugation
at 14 000 r.p.m. (CW), followed by ultracentrifugation at
55 000 r.p.m. for 120 min (CYT and ME). Total protein con-
centration of samples obtained from mycobacterial cultures in
Sauton medium was determined by using a Bradford protein
assay (Sigma-Aldrich).
Immunoblot analyses were carried out with rabbit anti-
PPE41 polyclonal serum (Abdallah et al., 2006), rabbit anti-
EsxN, a mouse monoclonal antibody raised against the
PGRS domain of PE_PGRS33 (Abdallah et al., 2009) or anti-
EsxA (Hyb76-8, Antibodyshop, Statens Serum Institut). As
control, culture supernatants were also analysed by Western
blot for the presence of GroEL2 (anti-GroEL2 monoclonal
antibody, Colorado State University, NIH, NIAID contract NO
AI75320), and PPE68, a PPE protein encoded by the ESX-1
locus, reported to be associated to the mycobacterial cell
envelope (Demangel et al., 2004).
Two dimensional gel electrophoresis
Culture filtrates from M. tuberculosis strains grown in Sauton
medium were concentrated in presence of EDTA-free pro-
tease inhibitor (Roche). Proteins were desalted and concen-
trated using the 2-D-Clean Up kit (GE Healthcare) and
resuspended in 2D buffer (7 M urea, 4% CHAPS, 5 mM DTT,
2% ampholytes pH 4-6). Forty micrograms of protein was
subjected to 2D gel electrophoresis using pH 4.5–5.5 immo-
bilized gradient strips for the first dimension (15 min at 200 V,
20 min at 450 V, 20 min at 750 V and 105 min at 2000 V), and
4–20% sodium dodecyl sulphate-polyacrylamide gel electro-
phoresis (SDS-PAGE) for separation in the second dimen-
sion (120 min at 200 V). EsxN detection was performed by
immunoblotting as mentioned above.
Proteinase K sensitivity assay
Proteinase-K treatment was performed as previously
reported (Cascioferro et al., 2007). Briefly, mycobacterial
strains were grown in Middlebrook 7H9 medium for 6 days.
Cells were washed in TBS buffer (150 mM NaCl, 3 mM KCl,
20 mM Tris-HCl, pH 7.5) and resuspended in 1 ml of the
same buffer. Each sample was divided in two identical ali-
quots, one of which was added to proteinase K (Sigma-
Aldrich) 100 mg ml-1. Treated and untreated samples were
incubated for 30 min at room temperature. The reaction was
stopped adding 1¥ complete EDTA-free protease inhibitor
(Roche). Samples were washed once in TBS and resus-
pended in 1¥ loading buffer (Sucrose 10% w/v, SDS 2%
w/v, Tris-HCl 1.36 mM, bromophenol blue 0.01% w/v,
b-mercaptoethanol 1% v/v). Equal amount of treated and
untreated samples were loaded on polyacrylamide gel and
tested in Western blotting as mentioned above.
SDS and drug sensitivity tests
Mutant, WT and complemented strains were grown to mid-
logarithmic phase in Middlebrook 7H9 medium supplemented
with 0.05% Tween 80. For detergent resistance/survival
assay, bacterial cultures were diluted at a final OD600 of 0.1,
and SDS was added to a final concentration of 0.1%. After 6,
24 and 72 h of incubation, the number of viable bacteria was
determined.
Drug sensitivity assays were performed as previously
described (Jackson et al., 1999). Bacterial suspensions were
plated on Middlebrook 7H11 medium containing twofold serial
dilutions of ampicillin (3.125–6400 mg ml-1), norfloxacin
(0.3125–40 mg ml-1), ofloxacin (0.03–4 mg ml-1), bacitracin
(1.56–800 mg ml-1), vancomycin (0.3125–40 mg ml-1), rifampi-
cin (0.0075–0.24 mg ml-1), isoniazid (0.125–2 mg ml-1), etham-
butol (0.8–6.4 mg ml-1).As control, bacterial suspensions were
plated on Middlebrook 7H11 medium without antibiotics. The
number of viable bacteria was determined after incubation of
plates at 37°C for 3 weeks. For each drug tested, the MIC
value was defined as the lowest concentration of antibiotic that
reduced the bacterial viability by at least 99% on solid medium.
Microplate-based nitrate reductase assay was performed on
mycobacterial cultures in exponential growth phase, as previ-
ously reported (Kumar et al., 2005).
Macrophage infection assays
Bone marrow-derived macrophages were obtained from
8-week-old C57BL/6 mice. Cells were seeded in a 96-well
plate at a density of 4 ¥ 104 cells per well and differentiated
into macrophages by culturing them for 7 days in RPMI
medium (Gibco) supplemented with 10% heat-inactivated
fetal calf serum, 10% L-cell conditioned medium, and 2 mM
L-glutamine. Macrophages were infected with bacterial sus-
pensions of M. tuberculosis H37Rv WT, KO and comple-
mented strains at an moi of 1:1 (bacteria : cell). At 4 h, or 1,
4 and 7 days after infection, infected cells were lysed by the
addition of 0.1% Triton X-100 (Fluka) in PBS. The number of
intracellular bacteria was determined by plating serial dilu-
tions of cell lysates on solid medium.
Mouse infection studies
Six-week-old CB17/Ico SCID mice (Charles River) were
infected intravenously with 1 ¥ 106 cfu per mouse of various
mycobacterial strains. Three weeks after infection mice were
sacrificed, and spleens and lungs were homogenized using
an MM300 apparatus (Qiagen) and 2.5-mm-diameter glass
beads. Serial fivefold dilutions of organ homogenates were
plated on solid medium, and the cfu were counted after
3–4 weeks of incubation at 37°C. All animal studies were
approved by the Institut Pasteur Safety Committee (Protocol
11.245; experimentation authorization number 75-1469), in
accordance with European and French guidelines (Directive
86/609/CEE and Decree 87–848 of 19 October 1987).
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